ÌÇÐÄvlog¹ÙÍø

Showing results 1 - 10 of 58

Harvard Kennedy School Logo
 
David Cutler, Edward Glaeser
May 29, 2025, Paper: "Scientists researching new cancer cures are neither culture warriors nor campus protesters. But so far, the biggest financial blows against academia have…
Harvard Kennedy School Logo
 
David Cutler
May 2025, Paper: "The growth of longevity in the U.S. and other countries has increased interest in raising the age of eligibility for public retirement benefits. The consequences…
Harvard Kennedy School Logo
 
David Cutler
February 27, 2025, Paper: "Clinicians and health policy researchers are tempted to evaluate the likely effects on health by the medical policies of the Trump administration, but…
David Cutler headshot
 
David Cutler
February 24, 2025, Paper: "Low-value care is a persistent problem with direct and cascading harms. Telemedicine is now commonly used and may reduce low-value testing by…
Harvard Kennedy School Logo
 
Edward Glaeser, David Cutler
2024, Opinion: "Cities are the nodes on our global lattice of travel and trade. They are the ports of entry for goods, people, ideas—and for viruses. The second of the…
Harvard Kennedy School Logo
 
Edward Glaeser, David Cutler
2024, Opinion: "Cities are the nodes on our global lattice of travel and trade. They are the ports of entry for goods, people, ideas—and for viruses. The second of the…
David Cutler Headshot
 
David Cutler
November 21, 2024, Paper: "There is a near-universal belief that health care costs too much. As a result, health care seems likely to fall once again under the budget axe. At the…
Harvard Kennedy School Logo
 
David Cutler
October 14, 2024, Paper: "U.S. opioid overdose death rates rose nearly continuously from 1990 to 2022, claiming over 750,000 lives. The persistence of the epidemic is surprising,…
Harvard Kennedy School Logo
 
David Cutler
2024, Paper: "This paper provides an examination of: (1) the frequency and net rates of change for general pediatric inpatient (GPI) unit closures and openings nationally and by…
David Cutler Headshot
 
David Cutler
August 15, 2024, Paper: "Glucagon-like peptide 1 (GLP-1) receptor agonists and dual GLP-1/gastric inhibitory polypeptide (GIP) receptor agonists are among the most promising…